期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | LEUKEMIA LetPub Score 9.1
50 ratings
Rate
Reputation 10.0 Influence 8.3 Speed 9.7 | ||||||||||||||||||||||||
期刊簡稱 | LEUKEMIA | ||||||||||||||||||||||||
ISSN | 0887-6924 | ||||||||||||||||||||||||
E-ISSN | 1476-5551 | ||||||||||||||||||||||||
h-index | 176 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.10%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.nature.com/leu | ||||||||||||||||||||||||
在線稿件提交 | https://mts-leu.nature.com/ | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1997 | ||||||||||||||||||||||||
每年文章數 | 186每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 54.56% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0887-6924%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Very difficult | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[LEUKEMIA] 的評論 | 撰寫評論 |
作者: 重阳凌文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-05 18:07:01 評論於 Friends, how long does it take for something to be under consideration? I've been waiting for over half a month(0) 讚! | 重阳凌文 |
作者: 小美 領域: 医学 審稿時間: 3.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-02 15:58:22 評論於 Friends, how long does "under consideration" usually last, and what stage does it belong to? It has been unchanged for over ten days ?(0) 讚! | 小美 |
作者: 宛旋小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-16 12:14:55 評論於 How long did it take for the OP to submit for review?(0) 讚! | 宛旋小公主 |
作者: 南川烨霖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-07 10:09:50 評論於 How do you know if you have been rejected? Did you receive an email, or does decision send to reviewers mean rejection?(0) 讚! | 南川烨霖 |
作者: 四风如彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-03 19:18:08 評論於 I was not asked to redo the experiment by the reviewers, just to revise the written content. The editor rejected it too(0) 讚! | 四风如彤 |
作者: 震雷暄妍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-27 23:09:22 評論於 Review Speed: 12.0 Experience Sharing: Academic editors feel busy and respond slowly(0) 讚! | 震雷暄妍 |
作者: 天际桂霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-26 21:54:23 評論於 I also want to know, does anyone know?(0) 讚! | 天际桂霞 |
作者: 天际桂霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-26 17:14:17 評論於 We think the same(0) 讚! | 天际桂霞 |
作者: 天际桂霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-26 12:07:25 評論於 I also want to know(0) 讚! | 天际桂霞 |
作者: 天际桂霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-26 09:06:34 評論於 May I ask what is the status of the external audit submission? Is it also under consideration?(0) 讚! | 天际桂霞 |
作者: 筑阳新春 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-22 12:04:39 評論於 It's a shame that I found out too late, thank you, senior(0) 讚! | 筑阳新春 |
作者: 墟散伟博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-14 19:46:01 評論於 Yes, leukemia tends to be more clinical, but if the mechanism is well studied, it's best to publish in basic journals like NC(0) 讚! | 墟散伟博 |
作者: 墟散伟博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-14 17:55:48 評論於 This means that there are too many images in each small image in your main image, and leikemia magazine is about to be published. The main image is too large to affect the layout space, so you need to transfer a large number of small images from the main image to the supplementary image(0) 讚! | 墟散伟博 |
作者: 活人幼珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-16 14:48:03 評論於 Could you please provide the submission process for the difficult magazine?(0) 讚! | 活人幼珊 |
作者: 碧水采香 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-16 08:43:59 評論於 Hello, do you know what this means? How many pictures do we need after all?(0) 讚! | 碧水采香 |
作者: 风啸俊衡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-14 12:41:20 評論於 I am also a reviewer and my opinions can completely resolve the issue, but they were rejected by the editor(0) 讚! | 风啸俊衡 |
作者: 风啸俊衡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-13 22:33:28 評論於 Review speed: 4.0 Emphasis on research direction: mechanism; Leukemia drug experience sharing: The review took three months, with two reviewers suggesting major revisions. The editor rejected the paper directly. It seems they value functionality more than mechanism(0) 讚! | 风啸俊衡 |
作者: 筑阳新春 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-24 11:22:59 評論於 The editor sent an email saying that figures are heavily overloaded, each figure with more than 3 subfigures count twice. Does anyone know what this means?(0) 讚! | 筑阳新春 |
作者: 法慧和同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-10 19:23:04 評論於 Field to be filled(0) 讚! | 法慧和同 |
作者: 法慧和同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-10 18:10:50 評論於 The associate editor should directly reject this(0) 讚! | 法慧和同 |
作者: 法慧和同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-10 18:10:17 評論於 Research Proposal(0) 讚! | 法慧和同 |
作者: 法慧和同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-10 17:15:41 評論於 Just wait a few more days(0) 讚! | 法慧和同 |
作者: Zora Taylor 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-10 08:45:53 評論於 Got rejected, sad(0) 讚! | Zora Taylor |
作者: Zora Taylor 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-05 16:16:06 評論於 A few days ago it was just submitted, and yesterday the status changed to "decision sent to reviewers." Does this mean it's being sent for external review? How strange. And it changed from "live manuscript" to "post decision." The author also didn't receive a rejection email. Has anyone else experienced a similar situation?(0) 讚! | Zora Taylor |
作者: 月河寻安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-01 12:01:33 評論於 Yes, who the editor is matters a lot. The questions raised by the reviewers are not negative, but they still rejected it. Maybe it was just bad luck(0) 讚! | 月河寻安 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us